Ming Li

Ming Li

Auto-generated profile, based on publicly available information

Ming Li

Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2020 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
RHRachel Hecht
Rachel Hecht
MLMing Li
Ming Li
QRQuirina M. B. de Ruiter
Quirina M. B. de Ruiter
WPWilliam F. Pritchard
William F. Pritchard
XLXiaobai Li
Xiaobai Li
BWBradford J Wood
Bradford J Wood

6 January 2021 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
DLDilara J. Long
Dilara J. Long
MLMing Li
Ming Li
QRQuirina M. B. De Ruiter
Quirina M. B. De Ruiter
RHRachel Hecht
Rachel Hecht
XLXiaobai Li
Xiaobai Li
SXSheng Xu
Sheng Xu

30 July 2020 in International Journal of Computer Assisted Radiology and Surgery
Verified
Journal Article
Closed access
PDF file
MLMing Li
Ming Li
RSReza Seifabadi
Reza Seifabadi
DLDilara Long
Dilara Long
QRQuirina De Ruiter
Quirina De Ruiter
NVNicole Varble
Nicole Varble
BWBradford J. Wood
Bradford J. Wood

29 November 2018 in Journal of Imaging
Verified
Journal Article
Open access
PDF file
RSReza Seifabadi
Reza Seifabadi
MLMing Li
Ming Li
SXSheng Xu
Sheng Xu
YCYue Chen
Yue Chen
ASAlex Squires
Alex Squires
BWBradford J. Wood
Bradford J. Wood
Purpose: A novel grid-template-mimicking MR-compatible robot was developed for in-gantry MRI-guided focal laser ablation of prostate cancer. Method: A substantially compact robot was designed and prototyped to meet in-gantry lithotomy ergonomics and allow for accommodation in the perineum. The controller software was reconfigured and integrated with the custom-designed navigation and multi-focal ablation software. Three experiments were conducted: (1) free space accuracy test; (2) phantom study under computed tomography (CT) guidance for image-guided accuracy test and overall workflow; and (3) magnetic resonance imaging (MRI)-guided focal laser ablation of an ex vivo prostate. The free space accuracy study included five targets that were selected across the workspace. The robot was then commanded five times to each target. The phantom study used a gel phantom made with color changing thermos-chromic ink, and four spherical metal fiducials were deployed with the robot. Then, laser ablation was applied, and the phantom was sliced for gross observation. For an MR-guided ex vivo test, a prostate from a donor who died of prostate cancer was obtained and multi-focally ablated using the system within the MRI gantry. The tissue was sliced after ablation for validation. Results: free-space accuracy was 0.38 ± 0.27 mm. The overall system targeting accuracy under CT guidance (including robot, registration, and insertion error) was 2.17 ± 0.47 mm. The planned ablation zone was successfully covered in both acrylamide gel phantom and in human prostate tissue. Conclusions: The new robot can accurately facilitate fiber targeting for MR-guided focal laser ablation of targetable prostate cancer.

16 March 2020
Verified
Conference Paper
Closed access
PDF file
RSReza Seifabadi
Reza Seifabadi
MLMing Li
Ming Li
DLDilara Long
Dilara Long
SXSheng Xu
Sheng Xu
BWBradford J Wood
Bradford J Wood
Purpose: This study aims to investigate the accuracy of a cross platform augmented reality (AR) system for percutaneous needle interventions irrespective of operator error. In particular, we study the effect of the relative position and orientation of the AR device and the marker, the location of the target, and the angle of needle on the overlay accuracy. Method: A needle guidance AR platform developed using Unity and Vuforia SDK platforms was used to display a planned needle trajectory for targets via mobile and wearable devices. To evaluate the system accuracy, a custom phantom embedded with metal fiducial markers and an adjustable needle guide was designed to mimic different relative position and orientation scenarios of the smart device and the marker. After segmenting images of CT-visible fiducial markers as well as different needle trajectories, error was defined by comparing them to the corresponding augmented target/needle trajectory projected by smartphone and smartglasses devices. Results: The augmentation error for targets and needle trajectories were reported as a function of marker position and orientation, as well as the location of the targets. Overall, the image overlay error for needle trajectory was 0.28±0.32° (Max = 0.856°) and 0.41±0.23° (Max = 0.805°) using the iPhone and HoloLens glasses, respectively. The overall image overlay error for targets was 1.75±0.59 mm for iPhone, and 1.74±0.86 mm for HoloLens. Conclusions: The image overlay error caused by different sources can be quantified for different AR devices.

21 May 2021 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
QRQuirina M. B. de Ruiter
Quirina M. B. de Ruiter
SXSheng Xu
Sheng Xu
MLMing Li
Ming Li
WPWilliam Pritchard
William Pritchard
MSMatthew F. Starost
Matthew F. Starost
BWBradford J Wood
Bradford J Wood